Trill Impact has been awarded as Impact Firm of the Year: Healthcare

The New Private Markets Global Awards celebrate private market firms and investors that have demonstrated excellence in Impact and ESG globally over the past year.

The award recognizes Trill Impact's value-creation initiatives in the healthcare sector and across portfolio companies, such as Cinclus Pharma, MinervaX, May Health, Mesalvo, and TT Medic, which support efforts to measurable impact, innovation, and improved healthcare outcomes. It also highlights how Trill Impact's Venture Capital Strategy has been engaging through industry conferences, panel discussions, and partnerships, fostering collaboration, and sharing best practices within the healthcare space.

The New Private Markets editorial team curated the shortlist, leveraging market insights alongside information from submissions. The final winners were selected by a panel of senior professionals from across PEI Group's various publications. The award was announced on March 3rd and recognizes impact-driven activities undertaken between November 17, 2023, and November 17, 2024, and highlights outstanding contributions in the field.

To view the complete list of winners, visit the link New Private Markets Awards 2024: Impact fund management winners